CYTOKINETICS, INCORPORATED (CYTK) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $20.51M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value $3.30M; Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $20.51M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $20.51M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | $3.30M | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Reported amount: $3.30M |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 2.10B USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 20.51M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current · Deferred Revenue, Noncurrent |
| Deferred revenue due within one year | 1.65M USD | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Deferred Revenue, Noncurrent · Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Reported other obligations due within one year | 3.30M USD | Other Liabilities, Current |
| Reported other noncurrent obligations | (m) | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- $3.30M
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $123.47M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $20.51M | (m) | $3.30M | (m) | $2.10B | (m) | $1.65M | (m) | (m) | (m) |
| 2026-03-31 | (m) | $24.71M | (m) | $8.59M | (m) | $2.10B | (m) | $1.65M | (m) | (m) | (m) |
| 2025-12-31 | (m) | $22.34M | (m) | $3.83M | (m) | $2.08B | (m) | $1.61M | (m) | (m) | (m) |
| 2025-09-30 | (m) | $22.08M | (m) | $1.99M | (m) | $1.96B | (m) | $1.61M | (m) | $1.61M | (m) |
| 2025-06-30 | (m) | $16.23M | (m) | $9.59M | (m) | $1.59B | (m) | $1.34M | (m) | $2.02M | (m) |
| 2025-03-31 | (m) | $13.94M | (m) | $5.82M | (m) | $1.53B | (m) | $52.37M | (m) | $2.82M | (m) |
| 2024-12-31 | (m) | $20.37M | (m) | $9.81M | (m) | $1.54B | (m) | $52.37M | (m) | $0.00 | (m) |
| 2024-09-30 | (m) | $11.58M | (m) | $5.53M | (m) | $1.45B | (m) | (m) | (m) | $0.00 | (m) |
| 2024-06-30 | (m) | $9.47M | (m) | $10.27M | (m) | $1.42B | (m) | (m) | (m) | $0.00 | (m) |
| 2024-03-31 | (m) | $12.97M | (m) | $6.01M | (m) | $1.20B | (m) | (m) | (m) | $2.00K | (m) |
| 2023-12-31 | (m) | $21.51M | (m) | $10.56M | (m) | $1.21B | (m) | (m) | (m) | $186.00K | (m) |
| 2023-09-30 | (m) | $13.80M | (m) | $13.74M | (m) | $1.18B | (m) | (m) | (m) | $408.00K | (m) |
| 2023-06-30 | (m) | $12.56M | (m) | $5.88M | (m) | $1.11B | (m) | (m) | (m) | $625.00K | (m) |
| 2023-03-31 | (m) | $17.36M | (m) | $7.97M | (m) | $1.12B | (m) | (m) | (m) | $837.00K | (m) |
| 2022-12-31 | (m) | $25.61M | (m) | $2.08M | $1.04M | $1.12B | (m) | (m) | $0.00 | $1.04M | $0.00 |
| 2022-09-30 | (m) | $14.43M | (m) | $5.78M | $1.25M | $1.09B | (m) | (m) | $0.00 | $1.25M | $0.00 |
| 2022-06-30 | (m) | $14.08M | (m) | $1.76M | $1.44M | $660.30M | (m) | (m) | $0.00 | $1.44M | $0.00 |
| 2022-03-31 | (m) | $19.84M | (m) | $3.04M | $3.21M | $739.99M | (m) | (m) | $87.00M | $3.21M | $0.00 |
| 2021-12-31 | (m) | $21.09M | (m) | $1.54M | $4.46M | $597.46M | (m) | (m) | $87.00M | $4.46M | $0.00 |
| 2021-09-30 | (m) | $16.22M | (m) | $2.41M | (m) | $578.52M | (m) | (m) | $87.00M | (m) | $0.00 |
| 2021-06-30 | (m) | $14.93M | (m) | $1.00M | (m) | $547.81M | (m) | (m) | $87.00M | (m) | $0.00 |
| 2021-03-31 | (m) | $7.77M | (m) | $2.44M | (m) | $509.22M | (m) | (m) | $87.00M | (m) | $0.00 |
| 2020-12-31 | (m) | $8.05M | (m) | $1.05M | (m) | $420.42M | (m) | (m) | $87.00M | (m) | $0.00 |
| 2020-09-30 | (m) | $6.74M | (m) | $2.41M | (m) | $324.51M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $2.92M | (m) | $1.01M | (m) | $310.57M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $3.53M | (m) | $2.51M | (m) | $302.29M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $8.16M | (m) | $1.12M | (m) | $300.75M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $3.41M | (m) | $389.00K | (m) | $207.26M | (m) | (m) | (m) | $0.00 | (m) |
| 2019-06-30 | (m) | $5.19M | (m) | $399.00K | (m) | $203.11M | (m) | (m) | (m) | $0.00 | (m) |
| 2019-03-31 | (m) | $2.55M | (m) | $75.00K | (m) | $195.24M | (m) | (m) | (m) | $0.00 | (m) |
| 2018-12-31 | (m) | $3.76M | $0.00 | $66.00K | $771.00K | $185.24M | (m) | $0.00 | $0.00 | $771.00K | $0.00 |
| 2018-09-30 | (m) | $2.02M | $0.00 | $38.00K | $873.00K | $178.21M | (m) | $0.00 | $0.00 | $873.00K | $0.00 |
| 2018-06-30 | (m) | $1.34M | $8.13M | $28.00K | $974.00K | $172.07M | (m) | $8.13M | $0.00 | $974.00K | $0.00 |
| 2018-03-31 | (m) | $2.42M | $15.84M | $235.00K | $1.03M | $180.33M | (m) | $15.84M | $0.00 | $1.03M | $0.00 |
| 2017-12-31 | (m) | $5.25M | $24.57M | $227.00K | $1.10M | $184.97M | (m) | $9.57M | $15.00M | $1.10M | $0.00 |
| 2017-09-30 | (m) | $4.08M | $25.44M | $424.00K | (m) | $179.28M | (m) | $9.57M | $15.87M | (m) | $0.00 |
| 2017-06-30 | (m) | $1.78M | $23.01M | $474.00K | $2.00K | $165.63M | (m) | $7.94M | $15.07M | $2.00K | $0.00 |
| 2017-03-31 | (m) | $3.04M | $25.97M | (m) | (m) | $169.99M | (m) | $10.97M | $15.00M | (m) | $0.00 |
| 2016-12-31 | (m) | $4.24M | $23.06M | (m) | (m) | $75.78M | (m) | $8.06M | $15.00M | (m) | $0.00 |
| 2016-09-30 | (m) | $668.00K | $26.13M | (m) | (m) | $74.92M | (m) | $10.50M | $15.63M | (m) | $0.00 |
| 2016-06-30 | (m) | $2.85M | $14.83M | (m) | (m) | $57.41M | (m) | $13.56M | $1.27M | (m) | $0.00 |
| 2016-03-31 | (m) | $547.00K | $16.76M | (m) | (m) | $55.31M | (m) | $15.91M | $851.00K | (m) | $0.00 |
| 2015-12-31 | (m) | $2.24M | $20.86M | (m) | (m) | $46.65M | (m) | $20.86M | $0.00 | (m) | $0.00 |
| 2015-09-30 | (m) | $1.91M | $25.71M | (m) | (m) | $34.90M | (m) | $21.37M | $4.35M | (m) | $0.00 |
| 2015-06-30 | (m) | $1.60M | $29.29M | (m) | (m) | $37.84M | (m) | $20.99M | $8.29M | (m) | $0.00 |
| 2015-03-31 | (m) | $1.39M | $32.15M | (m) | (m) | $38.06M | (m) | $19.94M | $12.21M | (m) | $0.00 |
| 2014-12-31 | (m) | $1.36M | $33.60M | (m) | (m) | $40.90M | (m) | $17.04M | $16.56M | (m) | $0.00 |
| 2014-09-30 | (m) | $1.65M | $5.34M | (m) | (m) | $13.55M | (m) | $5.28M | $52.00K | (m) | $0.00 |
| 2014-06-30 | (m) | $985.00K | (m) | (m) | (m) | $17.45M | (m) | $8.98M | (m) | (m) | (m) |
| 2014-03-31 | (m) | $1.69M | $11.17M | (m) | (m) | $21.10M | (m) | $10.40M | $772.00K | (m) | $0.00 |
| 2013-12-31 | (m) | $3.71M | $16.20M | (m) | (m) | $28.75M | (m) | $14.70M | $1.50M | (m) | $0.00 |
| 2013-09-30 | (m) | $1.79M | $36.02M | (m) | (m) | $48.26M | (m) | $33.32M | $2.70M | (m) | $0.00 |
| 2013-06-30 | (m) | $1.80M | $33.53M | (m) | (m) | $42.57M | (m) | $25.53M | $8.00M | (m) | $0.00 |
| 2013-03-31 | (m) | $1.09M | (m) | (m) | (m) | $6.26M | (m) | $43.00K | (m) | (m) | (m) |
| 2012-12-31 | (m) | $2.00M | (m) | (m) | (m) | $7.47M | (m) | $76.00K | (m) | (m) | (m) |
| 2012-09-30 | (m) | $1.52M | (m) | (m) | (m) | $4.74M | (m) | $129.00K | (m) | (m) | (m) |
| 2012-06-30 | (m) | $1.05M | (m) | (m) | (m) | $4.10M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $926.00K | (m) | (m) | (m) | $4.52M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $1.20M | (m) | (m) | (m) | $4.59M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $1.45M | (m) | (m) | (m) | $5.03M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $1.00M | (m) | (m) | (m) | $5.50M | (m) | $263.00K | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.12M | (m) | (m) | (m) | $7.48M | (m) | $0.00 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |